| P2093 | author name string | Deborah Holtzman | |
| | Nancy Glass | |
| | Francisco M Averhoff | |
| P2860 | cites work | Epidemiology of hepatitis C virus infection | Q22305500 |
| | Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews | Q24630669 |
| | Global epidemiology of hepatitis C virus infection | Q27860799 |
| | The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide | Q29616215 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt | Q30403548 |
| | The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt | Q33884428 |
| | Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt | Q34093173 |
| | Liver Disease in the HIV–Infected Individual | Q34380326 |
| | HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies | Q34561257 |
| | Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa | Q34683612 |
| | Hepatitis C and HIV-1 coinfection | Q35595027 |
| | Global burden of disease (GBD) for hepatitis C. | Q35610002 |
| | Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. | Q36562355 |
| | Global estimates of prevalence of HCV infection among injecting drug users. | Q36940143 |
| | Trends and projections of hepatitis C virus epidemiology in Latin America. | Q37886279 |
| | A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel | Q37886280 |
| | The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. | Q38438953 |
| | Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission | Q43000555 |
| | Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2. | Q43001405 |
| | The global burden of disease attributable to contaminated injections given in health care settings | Q43966617 |
| | Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. | Q47878759 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| | hepatitis C | Q154869 |
| P304 | page(s) | S10-5 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Global burden of hepatitis C: considerations for healthcare providers in the United States | |
| P478 | volume | 55 Suppl 1 | |